News & Events

  • October 13, 2015

    Nemaura Medical Announces Filing of Application for FDA Pre-Submission Program for sugarBEAT® System

    13th October 2015, Loughborough, UK. Nemaura Medical Inc. (OTC BB: NMRD),(“Nemaura”), a medical device company developing a minimally invasive...

    October 5, 2015

    Nemaura Medical Present Positive Interim Clinical Trial Results of its sugarBEAT® System

    5th October 2015, Nemaura Medical Inc. (OTC BB: NMRD),(“Nemaura”), a medical device company developing the sugarBEAT® CGM System as...

    May 1, 2015

    Nemaura Medical to Present Positive Interim Clinical Trial Results of its sugarBEAT® System at the Marcum Microcap Conference, New York

    Nemaura Medical Inc. (OTC BB: NMRD),(“Nemaura”), a medical device company developing the sugarBEAT® CGM System as a non-invasive, wireless...

    May 1, 2015

    Nemaura Medical to Present at the 2015 Marcum Microcap Conference

    Nemaura Medical Inc. (OTC BB: NMRD), a leading developer of minimally-invasive transdermal diagnostic technologies, announced today that Dr. D...

    July 1, 2014

    Nemaura Medical announces licensing deal with DB Pharma (Jersey) Ltd

    Nemaura Medical announces licensing deal with DB Pharma (Jersey) Ltd., for its unique non-invasive wireless continuous glucose monitoring Watch...